Cargando…
Mesenchymal Stem Cell-Mediated Therapy of Peripheral Artery Disease Is Stimulated by a Lamin A-Progerin Binding Inhibitor
OBJECTIVE: Human adipose tissue-derived mesenchymal stem cells (ASCs) have been reported to promote angiogenesis and tissue repair. However, poor survival and engraftment efficiency of transplanted ASCs are the major bottlenecks for therapeutic application. The present study aims to improve the ther...
Autores principales: | Heo, Soon Chul, Kwon, Yang Woo, Park, Gyu Tae, Kwon, Sang Mo, Bae, Sun Sik, Park, Bum-Joon, Kim, Jae Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Lipidology and Atherosclerosis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521968/ https://www.ncbi.nlm.nih.gov/pubmed/33024737 http://dx.doi.org/10.12997/jla.2020.9.3.460 |
Ejemplares similares
-
Progerin, an Aberrant Spliced Form of Lamin A, Is a Potential Therapeutic Target for HGPS
por: Kim, Bae-Hoon, et al.
Publicado: (2023) -
Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin A
por: Kang, So-mi, et al.
Publicado: (2021) -
Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome
por: Kang, So-mi, et al.
Publicado: (2021) -
Author Correction: Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin A
por: Kang, So‑mi, et al.
Publicado: (2021) -
Author Correction: Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome
por: Kang, So-mi, et al.
Publicado: (2021)